Duke Human Vaccine Institute
About:
DHIV develops novel vaccines and therapeutics and diagnosis for t infectious diseases that impact global health.
Website: https://dhvi.duke.edu
Twitter/X: TheDHVI
Top Investors: National Institute of Allergy and Infectious Diseases
Description:
The Duke Human Vaccine Institute develops vaccines and therapeutics against diseases of global importance.The investigators at the DHVI conduct basic and translational research to develop novel vaccines, therapeutics and diagnostics for diseases
Total Funding Amount:
$43.4M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Durham, North Carolina, United States
Founded Date:
1986-01-01
Contact Email:
dmca-agent(AT)duke.edu
Founders:
Number of Employees:
251-500
Last Funding Date:
2022-10-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai